The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice
Open accessAbstract
PURPOSE: Cerebral ischemia induces a profound neuro-inflammatory response, but the underlying molecular mechanisms are poorly understood. Inflammasomes (NLRP1, NLRP3, NLRC4, AIM2) are intracellular multi-protein complexes which can induce sets of pro-inflammatory cyto- and chemokines, and thereby guide inflammation. We, here, assessed the functional role of NLRP3 in ischemia/reperfusion (I/R) injury in a mouse model of transient cerebral ischemia. METHODS: Ischemic stroke was induced in C57Bl/6 mice by 60 min transient middle cerebral artery occlusion (tMCAO) and 3, 7 or 23 h of reperfusion, a paradigm of I/R injury. The expression patterns of inflammasomes in the ischemic hemispheres were evaluated by semiquantitative real-time PCR and Western Blot analysis accompanied by protein localization using immunocytochemistry. Finally, animals were treated with the inflammasome inhibitors Sulforaphane, Genipin, MCC950 or vehicle, directly before or upon recanalization after tMCAO. Stroke outcome was assessed, including infarct size and functional deficits, local inflammatory response, neuronal survival as well as blood-brain barrier function on day 1 after tMCAO. RESULTS: After tMCAO the relative gene expression levels of NLRP3 increased 20-30x within 1 day in the ischemic hemisphere which translated into an increased expression of NLRP3 in neurons. Accordingly, the gene expression levels of the NLRP3-modulator, Bruton's Tyrosine Kinase (BTK), and the NLRP3-inducible cytokine IL-1β significantly rose. Lesser or non-significant changes were seen for the other inflammasomes. Application of inflammasome inhibitors covering all inflammasomes or specifically NLRP3 significantly reduced infarct volumes when given before or after tMCAO and was accompanied by clear evidence for reduced activation of caspase 1. This stroke attenuating effect coincided with less immune cell infiltration in the ischemic hemisphere and preservation of the blood-brain barrier integrity. CONCLUSIONS: Our data show that induction of the NLRP3 inflammasome in neurons drives neuroinflammation in acute ischemic stroke. Early blockade of NLRP3 protects from I/R injury by mitigating inflammation and stabilizing the blood-brain barrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Bederson, J. B., Pitts, L. H., Tsuji, M., Nishimura, M. C., Davis, R. L., & Bartkowski, H. (1986) · Stroke · doi:10.1161/01.str.17.3.472 · Cited by 2,681
Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768 · cited 1×
“Thirdly, ASC filaments provide a docking site for pro-caspase 1 as effector molecule (Abulafia et al., 2009; Agostini et al., 2004; Deroide et al., 2013).”
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Baroja-Mazo, A., Martín-Sánchez, F., Gomez, A. I., Martínez, C. M., Amores-Iniesta, J., Compan, V., Barberà-Cremades, M., Yagüe, J., Ruiz-Ortiz, E., Antón, J., et al. (2014) · Nature Immunology · doi:10.1038/ni.2919 · Cited by 790 · cited 1×
“Our data extend previous studies showing the detrimental inflammatory effects of inflammasome activation already during the earliest phases of ischemic stroke (Baroja-Mazo et al., 2014; Ismael et al., 2018).”
The immunology of acute stroke
Chamorro, Á., Meisel, A., Planas, A. M., Urra, X., van de Beek, D., & Veltkamp, R. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.98 · Cited by 707
Yang-Wei Fann, D., Lee, S.-Y., Manzanero, S., Tang, S.-C., Gelderblom, M., Chunduri, P., Bernreuther, C., Glatzel, M., Cheng, Y.-L., Thundyil, J., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.326 · Cited by 475
Kleinschnitz, C., Stoll, G., Bendszus, M., Schuh, K., Pauer, H.-U., Burfeind, P., Renné, C., Gailani, D., Nieswandt, B., & Renné, T. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052458 · Cited by 452
Self-citationNLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke
Yang, F., Wang, Z., Wei, X., Han, H., Meng, X., Zhang, Y., Shi, W., Li, F., Xin, T., Pang, Q., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.242 · Cited by 422
Ito, M., Shichita, T., Okada, M., Komine, R., Noguchi, Y., Yoshimura, A., & Morita, R. (2015) · Nature Communications · doi:10.1038/ncomms8360 · Cited by 412
Thrombo-inflammation in acute ischaemic stroke — implications for treatment
Stoll, G., & Nieswandt, B. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0221-1 · Cited by 332
Self-citationAbulafia, D. P., de Rivero Vaccari, J. P., Lozano, J. D., Lotocki, G., Keane, R. W., & Dietrich, W. D. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.143 · Cited by 322 · cited 1×
“Thirdly, ASC filaments provide a docking site for pro-caspase 1 as effector molecule (Abulafia et al., 2009; Agostini et al., 2004; Deroide et al., 2013).”
Gotoh, O., Asano, T., Koide, T., & Takakura, K. (1985) · Stroke · doi:10.1161/01.str.16.1.101 · Cited by 303
Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke
Ismael, S., Zhao, L., Nasoohi, S., & Ishrat, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-24350-x · Cited by 236
Validity and Reliability of Neurological Scores in Mice Exposed to Middle Cerebral Artery Occlusion
Bieber, M., Gronewold, J., Scharf, A.-C., Schuhmann, M. K., Langhauser, F., Hopp, S., Mencl, S., Geuss, E., Leinweber, J., Guthmann, J., et al. (2019) · Stroke · doi:10.1161/strokeaha.119.026652 · Cited by 207
Self-citationAIM2 inflammasome contributes to brain injury and chronic post-stroke cognitive impairment in mice
Kim, H., Seo, J. S., Lee, S.-Y., Ha, K.-T., Choi, B. T., Shin, Y.-I., Ju Yun, Y., & Shin, H. K. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.011 · Cited by 187
Poh, L., Kang, S.-W., Baik, S.-H., Ng, G. Y. Q., She, D. T., Balaganapathy, P., Dheen, S. T., Magnus, T., Gelderblom, M., Sobey, C. G., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.09.001 · Cited by 183
The structure of rotational bands in alpha-cluster nuclei
Bijker, R. (2015) · EPJ Web of Conferences · doi:10.1051/epjconf/20159301011 · Cited by 180
Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism
Greaney, A. J., Maier, N. K., Leppla, S. H., & Moayeri, M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0415-155rr · Cited by 165
NLRP3 inflammasome in ischemic stroke: As possible therapeutic target
Alishahi, M., Farzaneh, M., Ghaedrahmati, F., Nejabatdoust, A., Sarkaki, A., & Khoshnam, S. E. (2019) · International Journal of Stroke · doi:10.1177/1747493019841242 · Cited by 152
MFGE8 inhibits inflammasome-induced IL-1β production and limits postischemic cerebral injury
Deroide, N., Li, X., Lerouet, D., Vré, E. A. V., Baker, L. L., Harrison, J., Poittevin, M., Masters, L. M., Nih, L. R., Margaill, I., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65167 · Cited by 144
Liu, X., Pichulik, T., Wolz, O., Dang, T., Stutz, A., Dillen, C. A., Garcia, M. D., Kraus, H., Dickhöfer, S., Daiber, E., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.017 · Cited by 141
Self-citationMurthy, P., Durco, F., Miller-Ocuin, J. L., Takedai, T., Shankar, S., Liang, X., Liu, X., Cui, X. D., Sachdev, U., Rath, D., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.161 · Cited by 114
Self-citationJander, S., Schroeter, M., & Stoll, G. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200201000-00008 · Cited by 106
Self-citationThe role of the inflammasome in patients with autoinflammatory diseases
Hoffman, H. M., & Broderick, L. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.001 · Cited by 103
Schuhmann, M. K., Kraft, P., Stoll, G., Lorenz, K., Meuth, S. G., Wiendl, H., Nieswandt, B., Sparwasser, T. D., Beyersdorf, N., Kerkau, T., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.175 · Cited by 96
Self-citationRoth, S., Singh, V., Tiedt, S., Schindler, L., Huber, G. C., Geerlof, A., Antoine, D. J., Anfray, A., Orset, C., Gauberti, M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao1313 · Cited by 93
BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity
Bittner, Z., Liu, X., Tortola, M. M., Tapia‐Abellán, A., Shankar, S., Andreeva, L., Mangan, M., Spalinger, M. R., Kalbacher, H., Duewell, P., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201656 · Cited by 88
Self-citationWong, R., Lénárt, N., Hill, L., Toms, L., Coutts, G., Martinecz, B., Császár, E., Nyíri, G., Papaemmanouil, A., Waisman, A., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.012 · Cited by 83
Huang, M., Tu, C.-E., Wang, S., Hung, Y., Su, C., Fang, S., Chen, C., Liu, P., Cheng, W., Huang, Y., et al. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2287-5 · Cited by 82
Yu, C., He, Q., Zheng, J., Li, L. Y., Hou, Y. H., & Song, F. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.01.034 · Cited by 76
Cao, Y., Zhang, H., Lu, X., Wang, J., Zhang, X., Sun, S., Bao, Z., Tian, W., Ning, S., Wang, L., et al. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.01.008 · Cited by 61
Gasdermin Family: a Promising Therapeutic Target for Stroke
Chen, S., Mei, S., Luo, Y., Wu, H., Zhang, J., & Zhu, J. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0666-3 · Cited by 58
Genipin suppresses NLRP3 inflammasome activation through uncoupling protein-2
Rajanbabu, V., Galam, L., Fukumoto, J., Enciso, J., Tadikonda, P., Lane, T., Bandyopadhyay, S., Parthasarathy, P. T., Cho, Y., Cho, S., et al. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.06.002 · Cited by 50
Sex differences in regulatory cells in experimental stroke
Seifert, H. A., Benedek, G., Liang, J., Nguyen, H., Kent, G., Vandenbark, A. A., Saugstad, J. A., & Offner, H. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.06.003 · Cited by 49
Bieber, M., Schuhmann, M. K., Volz, J., Gangasani, J. K., Vaidya, J. R., Nieswandt, B., Pham, M., Stoll, G., Kleinschnitz, C., & Kraft, P. (2018) · Stroke · doi:10.1161/strokeaha.118.023664 · Cited by 41
Self-citation
Cited by
NLRP3 and pyroptosis blockers for treating inflammatory diseases
Coll, R. C., Schroder, K., & Pelegrín, P. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.04.003 · Cited by 755
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
Tuo, Q., Zhang, S., & Lei, P. (2022) · Medicinal Research Reviews · doi:10.1002/med.21817 · Cited by 728
Zhu, H., Jian, Z., Zhong, Y., Ye, Y., Zhang, Y., Hu, X., Pu, B., Gu, L., & Xiong, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714943 · Cited by 370
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Xu, W., Huang, Y., & Zhou, R. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01275-w · Cited by 295
Migraine and neuroinflammation: the inflammasome perspective
Kursun, O., Yemisci, M., van den Maagdenberg, A. M. J. M., & Karatas, H. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01271-1 · Cited by 266
Metadata
- Authors
- Franke, M., Bieber, M., Kraft, P., Weber, A. N. R., Stoll, G., & Schuhmann, M. K.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 92
- Pages
- 221-231
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W3112310683
- Cited by
- 382
- References
- 38
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.